Journals / Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2020 / Cilt: 7 - Sayı: 4

Investigation of Glucose, Lipid, Chromium Level Changes in Gestational Diabetic and Nondiabetic Pregnants Compared with Healthy Groups

Gestasyonel Diyabetik ve Nondiyabetik Gebelerin Glukoz, Lipid, Krom Seviyelerinin Sağlıklı Gruplara Göre Değişimlerinin İncelenmesi

Pages
489–494
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It seems to be on his role in diabetes, to include the level of chromium in the tissue offuture research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, it is aimed to investigate the changes and interactions of these metabolic parameters inpregnancy and gestational diabetes and by studying fasting blood sugar, total cholesterol, triglyceride and plasmachromium parameters, in blood samples of pregnant women diagnosed with gestational diabetes, pregnantwomen without diabetes and healthy women who are not pregnant in the same age groupMaterials and Methods: This study included 50 pregnant women with gestational diabetes, 50 healthy pregnantwomen without diabetes and 50 healthy non-pregnant women in the same age group.
📊
Key Findings & Data:It was measured fastingblood sugar, total cholesterol, triglyceride and plasma chromium concentrations in blood samples taken from thepatient and control groupsResults: Fasting blood sugar and plasma chromium levels of gestational diabetes group were significantly higherthan the other two groups (p <0.05).
💡
Conclusion & Impact:It seems to be on his role in diabetes, to include the level of chromium in the tissue offuture research.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gestasyonel Diyabetes Mellitus · Krom · Glukoz

Abstract

Aim: In this study, it is aimed to investigate the changes and interactions of these metabolic parameters inpregnancy and gestational diabetes and by studying fasting blood sugar, total cholesterol, triglyceride and plasmachromium parameters, in blood samples of pregnant women diagnosed with gestational diabetes, pregnantwomen without diabetes and healthy women who are not pregnant in the same age groupMaterials and Methods: This study included 50 pregnant women with gestational diabetes, 50 healthy pregnantwomen without diabetes and 50 healthy non-pregnant women in the same age group. It was measured fastingblood sugar, total cholesterol, triglyceride and plasma chromium concentrations in blood samples taken from thepatient and control groupsResults: Fasting blood sugar and plasma chromium levels of gestational diabetes group were significantly higherthan the other two groups (p <0.05). While the total cholesterol and triglyceride levels of the gestational diabetesgroup were significantly higher than the control group (p <0.05), there was no significant difference from the non-diabetic group. Triglyceride and plasma chromium levels of non-diabetic pregnant group were higher thanthe control group (p <0.05). Plasma chromium levels shows a positive correlation with Body mass index, totalcholesterol and triglyceride levels of all groups.Conclusion: In this study, chromium levels in gestational diabetes mellitus patients were found to besignificantly higher than the other two groups. A positive correlation was found between plasma chromium andBody mass index, triglyceride and total cholesterol levels. There are quite contradictory publications on all typesof diabetes and chromium. It seems to be on his role in diabetes, to include the level of chromium in the tissue offuture research.

Özet

Öz Amaç: Bu çalışmada, gestasyonel diyabet tanısı almış ve diyabetli olmayan gebeler ile aynı yaş grubunda gebe olmayan sağlıklı kadın bireylerin Açlık Kan Şekeri (AKŞ), total kolesterol, trigliserit, ve plazma krom (Cr) parametreleri çalışılarak, bu metabolik parametrelerin, gebelik ile gestasyonel diyabetteki değişimleri ve birbirleri ile etkileşimlerinin incelenmesi amaçlanmıştır. Gereç ve Yöntem: Bu çalışmaya, 50 adet gestasyonel diyabetli(GDM) gebe, 50 adet diyabetli olmayan sağlıklı gebe ile 50 adet aynı yaş grubunda olan gebe olmayan sağlıklı kadın birey dahil edilmiştir. Hasta ve kontrol grubundan alınan kan örneklerinde AKŞ, total kolesterol, trigliserit ve plazma Cr konsantrasyonları ölçülmüştür. Bulgular: GDM’li grubun AKŞ ve plazma Cr düzeyleri, diğer iki gruptan anlamlı yüksek çıkmıştır(p<0.05). GDM’li grubun total kolesterol ve trigliserit düzeyleri kontrol grubuna göre anlamlı yüksek çıkarken(p<0.05), nondiyabetik gruptan anlamlı bir fark bulunmamıştır. Nondiyabetik gebe grubun trigliserit ve plazma Cr düzeyleri, kontrol grubuna göre yüksek bulunmuştur(p<0.05). Buna ek olarak tüm grupların plazma Cr düzeyleri; vücut kitle indeksi (VKİ), total kolesterol ve trigliserit düzeyleri ile pozitif korelasyon göstermektedir. Sonuçlar: Bu çalışmada GDM’li hastalarda krom düzeyleri diğer iki gruba göre anlamlı olarak yüksek bulunmuştur. Plazma krom ile VKİ, trigliserit ve total kolesterol düzeyleri arasında pozitif korelasyon saptanmıştır. Krom ve diyabetin tüm türleri ile ilgili oldukça çelişkili yayınlar vardır, gelecekteki araştırmaların dokuda krom düzeyini de kapsayacak biçimde, diyabetteki rolü üzerine olacağı görülmektedir.

🔖

Cite This Article

KESKİN, A., DORMAN, E. (2020). Investigation of Glucose, Lipid, Chromium Level Changes in Gestational Diabetic and Nondiabetic Pregnants Compared with Healthy Groups. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Cilt: 7 - Sayı: 4, 489–494. https://ajindex.com/articles/208265

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Turok, D, K, Ratcliffe, S, D, Baxley, E, G, Management of gestational diabetes mellitus, American Family Physician, 2003, 68, 1767-1772
  2. Harris, S, B, Caulfield, L, E, Sugamori, M, E, Whalen, E, A, Henning, B, The epidemiology of diabetes in pregnant native canadians. a risk profile, Diabetes Care, 1997, 20, 1422-1427
  3. Mazze, R, S, Krogh, C, L, Gestational diabetes mellitus: Now is the time for detection and treatment, Mayo Clinic Proceedings, 1992, 67, 995-1002
  4. Langer, O, Yogev, Y, Most, O, Xenakis, E, M, Gestational diabetes: The consequences of not treating. American Journal Of Obstetrics & Gynecology, 2005,192, 989-997
  5. Fan, Z, T, Yang, H, X, Gao, X, L, Lintu, H, Sun, W, J, Pregnancy outcome in gestational diabetes, International Journal Of Gynecology & Obstetrics, 2006, 94, 12-18
  6. Moore, P, Kolterman, O, Weyant, J, Olefsky, J, M, Insulin binding in human pregnancy: comparisons to the postpartum, luteal, and follicular states. The Journal Of Clinical Endocrinology & Metabolism, 1981, 52, 937-941
  7. Menato, G, Bo, S, Signorile, A, Current management of gestational diabetes mellitus, Expert Review Of Obstetrics & Gynecology, 2008, 3, 73-91
  8. Takiishi, T, Gysemans, C, Bouillon, R, Mathieu, C, Vitamin D and diabetes. Endocrinology and Metabolism Clinics Of North America, 2010, 39, 419-446
  9. Silverman, B, L, Rizzo, T, Cho, N, H, Metzger, B, E, Long-term effects of the intrauterine environment, The Northwestern University Diabetes İn Pregnancy Center Diabetes Care, 1998, 21 Suppl 2, 142-151
  10. Knowler, W, C, Barrett, Connor, E, Fowler, S, E, Hamman, R, F, Lachin, J, M, Walker, E, A, Nathan, D, M, Diabetes prevention program research g. reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, New England Journal Of Medicine, 2002, 346, 393-403
  11. Lewicki, S, Zdanowski, R, Krzyzowska, M, Lewicka, A, Debski, B, Niemcewicz, M, et al, The role of chromium III in the organism and its possible use in diabetes and obesity treatment, Ann Agrienv Medicine, 2014, 2, 331–335
  12. Davidson, I, Burt, R, Physiologic changes in plazma chromium of normal and pregnant women: Effect of a glucose load, American Journal of Obstetrics and Gynecology, 1973, 116, 601– 608
  13. Morris, B, W, Samaniego, S, Fraser, R, Macneil S, Increased chromium excretion in pregnancy is associated with insulin resistance, The Journal of Trace Elements in Experimental Medicine, 2000, 13, 389 –396
  14. Cosson, E, Benchimol, M, Carbillon, L, U